LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock
Shares outstanding
37,435,082
Number of holders
92
Total 13F shares, excl. options
25,969,624
Shares change
-582,816
Total reported value, excl. options
$275,201,016
Value change
-$6,203,031
Number of buys
37
Number of sells
-44
Price
$10.60

Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q1 2021

99 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q1 2021.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 25,969,624 shares of 37,435,082 outstanding shares and own 69.4% of the company stock.
Largest 10 shareholders include Legion Partners Asset Management, LLC (2,928,090 shares), WYNNEFIELD CAPITAL INC (2,905,300 shares), BlackRock Inc. (2,183,158 shares), DIMENSIONAL FUND ADVISORS LP (2,136,480 shares), VANGUARD GROUP INC (1,679,164 shares), Cove Street Capital, LLC (1,679,138 shares), HEARTLAND ADVISORS INC (1,232,190 shares), Russell Investments Group, Ltd. (1,180,729 shares), INVESTMENT COUNSELORS OF MARYLAND LLC (1,139,877 shares), and KENNEDY CAPITAL MANAGEMENT, INC. (1,118,858 shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.